WallStreetZenWallStreetZen

NASDAQ: LEGN
Legend Biotech Corp Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for LEGN

Based on 6 analysts offering 12 month price targets for Legend Biotech Corp.
Min Forecast
$53.00-1.03%
Avg Forecast
$64.50+20.45%
Max Forecast
$77.00+43.79%

Should I buy or sell LEGN stock?

Based on 9 analysts offering ratings for Legend Biotech Corp.
Strong Buy
Strong Buy
5 analysts 55.56%
Buy
3 analysts 33.33%
Hold
1 analysts 11.11%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LEGN stock forecasts and price targets.

LEGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JP Morgan
Top 7%
94
Strong BuyMaintains$65.00+21.38%2022-12-06Find out why
UBS
Bottom 19%
19
Strong BuyInitiates Coverage On$66.00+23.25%2022-12-06
Evercore ISI Group
Bottom 11%
11
BuyInitiates Coverage OnN/AN/A2022-11-02
Cowen & Co.
Bottom 5%
5
BuyInitiates Coverage OnN/AN/A2022-11-01
Guggenheim
Bottom 41%
41
HoldInitiates Coverage OnN/AN/A2022-10-31
Morgan Stanley
Bottom 4%
4
Strong BuyMaintains$60.00+12.04%2022-10-13
BMO Capital
Top 31%
70
BuyInitiates Coverage On$77.00+43.79%2022-06-17
Barclays
Top 17%
84
Strong BuyInitiates Coverage On$53.00-1.03%2022-03-15
Anonymous
Morgan Stanley
Strong BuyMaintains$55.00+2.71%2022-03-07
Piper Sandler
Top 18%
83
Strong BuyInitiates Coverage On$66.00+23.25%2021-12-21

1 of 1

Forecast return on equity

Is LEGN forecast to generate an efficient return?
Company
156.26%
Industry
14.81%
Market
62.61%
LEGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LEGN forecast to generate an efficient return on assets?
Company
65.86%
Industry
13.32%
LEGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LEGN earnings per share forecast

What is LEGN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$2.31
Avg 2 year Forecast
-$2.77
Avg 3 year Forecast
-$0.26

LEGN revenue forecast

What is LEGN's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$184.2M+57.51%
Avg 2 year Forecast
$210.1M+79.63%
Avg 3 year Forecast
$497.4M+325.32%
LEGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LEGN revenue growth forecast

How is LEGN forecast to perform vs Biotechnology companies and vs the US market?
Company
55.81%
Industry
23.98%
Market
6.66%
LEGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LEGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LEGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LEGN$53.55$64.50+20.45%Strong Buy
HALO$56.93$60.17+5.69%Strong Buy
JAZZ$151.95$198.78+30.82%Strong Buy
KRTX$197.28$270.46+37.10%Strong Buy
ASND$117.07$151.67+29.55%Strong Buy

Legend Biotech Stock Forecast FAQ

Is Legend Biotech Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: LEGN) stock is to Strong Buy LEGN stock.

Out of 9 analysts, 5 (55.56%) are recommending LEGN as a Strong Buy, 3 (33.33%) are recommending LEGN as a Buy, 1 (11.11%) are recommending LEGN as a Hold, 0 (0%) are recommending LEGN as a Sell, and 0 (0%) are recommending LEGN as a Strong Sell.

If you're new to stock investing, here's how to buy Legend Biotech stock.

What is LEGN's earnings growth forecast for 2022-2024?

(NASDAQ: LEGN) Legend Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Legend Biotech's earnings in 2022 is -$346,397,000.On average, 4 Wall Street analysts forecast LEGN's earnings for 2022 to be -$713,094,769, with the lowest LEGN earnings forecast at -$864,357,295, and the highest LEGN earnings forecast at -$459,961,561. On average, 3 Wall Street analysts forecast LEGN's earnings for 2023 to be -$855,096,324, with the lowest LEGN earnings forecast at -$1,234,796,136, and the highest LEGN earnings forecast at -$617,398,068.

In 2024, LEGN is forecast to generate -$80,261,749 in earnings, with the lowest earnings forecast at -$388,960,783 and the highest earnings forecast at $330,307,966.

What is LEGN's revenue growth forecast for 2022-2024?

(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 55.81% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 23.98%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.66%.

Legend Biotech's revenue in 2022 is $116,937,000.On average, 4 Wall Street analysts forecast LEGN's revenue for 2022 to be $56,856,805,480, with the lowest LEGN revenue forecast at $40,624,792,874, and the highest LEGN revenue forecast at $77,174,758,500. On average, 4 Wall Street analysts forecast LEGN's revenue for 2023 to be $64,844,084,286, with the lowest LEGN revenue forecast at $31,811,435,454, and the highest LEGN revenue forecast at $78,592,921,862.

In 2024, LEGN is forecast to generate $153,534,551,550 in revenue, with the lowest revenue forecast at $137,747,991,651 and the highest revenue forecast at $176,699,327,062.

What is LEGN's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: LEGN) forecast ROA is 65.86%, which is higher than the forecast US Biotechnology industry average of 13.32%.

What is LEGN's Price Target?

According to 6 Wall Street analysts that have issued a 1 year LEGN price target, the average LEGN price target is $64.50, with the highest LEGN stock price forecast at $77.00 and the lowest LEGN stock price forecast at $53.00.

On average, Wall Street analysts predict that Legend Biotech's share price could reach $64.50 by Dec 6, 2023. The average Legend Biotech stock price prediction forecasts a potential upside of 20.45% from the current LEGN share price of $53.55.

What is LEGN's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: LEGN) Legend Biotech's current Earnings Per Share (EPS) is -$2.40. On average, analysts forecast that LEGN's EPS will be -$2.31 for 2022, with the lowest EPS forecast at -$2.80, and the highest EPS forecast at -$1.49. On average, analysts forecast that LEGN's EPS will be -$2.77 for 2023, with the lowest EPS forecast at -$4.00, and the highest EPS forecast at -$2.00. In 2024, LEGN's EPS is forecast to hit -$0.26 (min: -$1.26, max: $1.07).

What is LEGN's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: LEGN) forecast ROE is 156.26%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.